CAPITOL COUNSEL LLC

Lobbying for ALNYLAM PHARMACEUTICALS, INC. · Pharmaceutical manufacturer.

Filing 3rd Quarter - Report

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 15, 2025

Income

$30,000.00

What the client paid this registrant for the period.

Client based in

Massachusetts

Government bodies contacted 1

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 1

Medical/Disease Research/Clinical Labs

Issues regarding FDA guidance on Platform Technology Platform Technology Designation Program for Drug Development.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.